Humoral Immune Response of SARS‐CoV‐2–Infected Patients with Cancer: Influencing Factors and Mechanisms

BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)–infected patients with cancer show worse outcomes compared with patients without cancer. The humoral immune response (HIR) of patients with cancer against SARS‐CoV‐2 is not well characterized. To better understand it, we conduc...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncologist
Main Authors: Esperança‐Martins, Miguel, Gonçalves, Lisa, Soares‐Pinho, Inês, Gomes, Andreia, Serrano, Marta, Blankenhaus, Birte, Figueiredo‐Campos, Patrícia, Catarina‐Marques, Ana, Castro‐Barbosa, Ana, Cardoso, Ana, Antunes‐Meireles, Pedro, Atalaia‐Barbacena, Henrique, Gaspar, Pedro, Howell‐Monteiro, Patrícia, Pais‐de‐Lacerda, António, Mota, Catarina, Veldhoen, Marc
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Inc. 2021
Assuntos:
Immuno‐Oncology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8242329/
https://ncbi.nlm.nih.gov/pubmed/34018280
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/onco.13828
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados